Companies · USAspending parent record
ROCHE HOLDING AG
No confirmed stock ticker. 3 recipient records grouped under this USAspending parent (UEI WJHDT127L353).
obligated to date on 11 non-competed awards of $1M+ signed FY2024–26
Not recently updated
Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.
11 non-competed ($1M+) · 8 other ($10M+)
Not recently updated
obligated to date: 75A50325F80003, Department of Health and Human Services, signed FY2025
Not recently updated
No confirmed stock ticker, so no member trades are matched to this company.
Federal contract awards in our records
Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.
What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.
| Signed in | Non-competed awards | Obligated to date | Other awards $10M+ | Obligated to date |
|---|---|---|---|---|
| FY2024 | 4 | $6.2M | 3 | $57.8M |
| FY2025 | 4 | $6.8M | 4 | $128M |
| FY2026incomplete | 3 | $4.3M | 1 | $22.0M |
FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.
| Source | ||||||
|---|---|---|---|---|---|---|
| 75A50325F80003Order under IDV 36F79723D0219OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES | GENENTECH USA, INC | Department of Health and Human Services | Jan 29, 2025FY2025 | Full and open competition | $45,106,864 | USAspending |
| 75A50325F80036Order under IDV 36F79723D0219PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS | GENENTECH USA, INC | Department of Health and Human Services | Sep 26, 2025FY2025 | Full and open competition | $37,485,000 | USAspending |
| 36C10G25F0005Order under IDV 36C10G24D0059TASK ORDER FOR BASE YEAR | FOUNDATION MEDICINE, INC. | Department of Veterans Affairs | Oct 4, 2024FY2025 | Competed under SAP | $24,000,010 | USAspending |
| 36C10G25F0019Order under IDV 36C10G24D0059MODIFICATION P1 TO ADD AN ADDITIONAL POC FOR FMI AND ADDITIONAL REPORT | FOUNDATION MEDICINE, INC. | Department of Veterans Affairs | Sep 29, 2025FY2025 | Competed under SAP | $21,581,260 | USAspending |
| 36C24725C0053MOLECULAR ANALYZER REAGENTS & MAINTENANCE | ROCHE DIAGNOSTICS CORPORATION | Department of Veterans Affairs | Mar 7, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $1,965,106 | USAspending |
| W81K0225FA154Order under IDV W81K0225DA021REAGENTS, SUPPLIES, TRAINING AND MAINTENANCE FOR THE GOVERNMENT OWNED ROCHE DIAGNOSTIC TOTAL LABORATORY AUTOMATION SYSTEM. | ROCHE DIAGNOSTICS CORPORATION | Department of Defense | Sep 18, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $1,947,948 | USAspending |
| HT001425F0052Order under IDV HT001425A0014SIX MONTHS SLIDE STAINING REAGENT RENTAL | ROCHE DIAGNOSTICS CORPORATION | Department of Defense | Jun 25, 2025FY2025 | Not competed under SAPSAP non-competition (FAR 13) | $1,615,681 | USAspending |
| 36C24125N0745Order under IDV 36C24124A0052VENTANA HISTOLOGY REAGENTS | ROCHE DIAGNOSTICS CORPORATION | Department of Veterans Affairs | Apr 9, 2025FY2025 | Not competed under SAPSAP non-competition (FAR 13) | $1,240,478 | USAspending |
FY2025 awards to ROCHE HOLDING AG, largest first (obligated to date)
- 75A50325F80003Order under IDV 36F79723D0219OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULESGENENTECH USA, INC
- Signed
- Jan 29, 2025FY2025
- Competition
- Full and open competition
- Obligated to date
- $45,106,864
- 75A50325F80036Order under IDV 36F79723D0219PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETSGENENTECH USA, INC
- Signed
- Sep 26, 2025FY2025
- Competition
- Full and open competition
- Obligated to date
- $37,485,000
- 36C10G25F0005Order under IDV 36C10G24D0059TASK ORDER FOR BASE YEARFOUNDATION MEDICINE, INC.
- Signed
- Oct 4, 2024FY2025
- Competition
- Competed under SAP
- Obligated to date
- $24,000,010
- 36C10G25F0019Order under IDV 36C10G24D0059MODIFICATION P1 TO ADD AN ADDITIONAL POC FOR FMI AND ADDITIONAL REPORTFOUNDATION MEDICINE, INC.
- Signed
- Sep 29, 2025FY2025
- Competition
- Competed under SAP
- Obligated to date
- $21,581,260
- 36C24725C0053MOLECULAR ANALYZER REAGENTS & MAINTENANCEROCHE DIAGNOSTICS CORPORATION
- Signed
- Mar 7, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $1,965,106
- W81K0225FA154Order under IDV W81K0225DA021REAGENTS, SUPPLIES, TRAINING AND MAINTENANCE FOR THE GOVERNMENT OWNED ROCHE DIAGNOSTIC TOTAL LABORATORY AUTOMATION SYSTEM.ROCHE DIAGNOSTICS CORPORATION
- Agency
- Department of Defense
- Signed
- Sep 18, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $1,947,948
- HT001425F0052Order under IDV HT001425A0014SIX MONTHS SLIDE STAINING REAGENT RENTALROCHE DIAGNOSTICS CORPORATION
- Agency
- Department of Defense
- Signed
- Jun 25, 2025FY2025
- Competition
- Not competed under SAPSAP non-competition (FAR 13)
- Obligated to date
- $1,615,681
- 36C24125N0745Order under IDV 36C24124A0052VENTANA HISTOLOGY REAGENTSROCHE DIAGNOSTICS CORPORATION
- Signed
- Apr 9, 2025FY2025
- Competition
- Not competed under SAPSAP non-competition (FAR 13)
- Obligated to date
- $1,240,478
Recipient records grouped under this company (3)
USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to ROCHE HOLDING AG; the stock link below is made per recipient.
- ROCHE DIAGNOSTICS CORPORATION12 awards · 11 non-competed, $17.3M obligated to date
- FOUNDATION MEDICINE, INC.4 awards
- GENENTECH USA, INC3 awards
Stock ticker
Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.
Members of Congress who reported trading this stock
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.
Looking for agency-level shares? See non-competed share by agency.